Lv2
190 积分 2024-01-09 加入
Influence of pharmacokinetics-related polymorphisms on asciminib exposure in patients with Japanese chronic myeloid leukemia
2个月前
已完结
Exposure-response analysis of asciminib efficacy and safety in patients with chronic myelogenous leukemia in chronic phase
3个月前
已完结
Advances and Controversies in the Management of Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: Navigating First-Line Therapies
3个月前
已完结
Explainable Clinical AI Decision-Making for Myeloproliferative Neoplasms: Integration of Consumer-Grade Wearable Monitors for Real-Time Risk Assessment and Treatment Optimization
4个月前
已完结
How I individualize frontline treatment for chronic-phase CML
5个月前
已完结
How I approach hematopoietic stem cell transplantation for CML in a TKI world
5个月前
已完结
How I Treat Advanced Phases of CML
5个月前
已完结
Impact of ASXL1 at diagnosis in patients with CML receiving frontline potent TKIs: high risk of kinase domain mutations
7个月前
已完结
Comprehensive resistance profiling of chronic myeloid leukaemia associated ABL1 variants against five tyrosine kinase inhibitors using prime editing
8个月前
已完结
Impact of ASXL1 at diagnosis in patients with CML receiving frontline potent TKIs: high risk of kinase domain mutations
8个月前
已关闭
皖公网安备34019202002308
